Zymeworks Inc. (ZYME)
$28.77+0.35%Close
BUYRECOVERY · day 15
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $2.1B
- Avg volume
- 609.0K
- Beta
- 1.15
- P/E (TTM)
- -14.24
- Short % float
- 6.04%
- Days to cover
- 10.9
- SI change
- +0.1%
- 1W
- +13.67%
- 1M
- +25.85%
- 3M
- +12.34%
- YTD
- +8.08%
- vs SPY 1W
- +14.86%
- vs SPY 1M
- +22.53%
- vs SPY 3M
- +9.95%
- vs SPY YTD
- -3.68%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- AVRBUYAnteris Technologies Global Corp.RECOVERYQ 31$8.80-2.00%
- NOTVSELLInotiv, Inc.CRISISQ -1$0.01+0.00%
- CATXBUYPerspective Therapeutics, Inc.RECOVERYQ 7$3.19-3.33%
- CLPTBUYClearPoint Neuro, Inc.RECOVERYQ 7$15.17-1.43%
- GELSSELLGelteq Limited Ordinary SharesCRISISQ -13$0.53-5.36%
- ACONBUYAclarion, Inc.RECOVERYQ -29$2.66-1.85%
- XNCRBUYXencor, Inc.BULLQ 17$29.00+4.32%
- RLAYBUYRelay Therapeutics, Inc.BULLQ 4$19.76+1.65%
- LEXXBUYLexaria Bioscience Corp.RECOVERYQ -8$10.54-3.48%
- ALTBUYAltimmune, Inc.RECOVERYQ -5$3.11+0.00%
- BMGLSELLBasel Medical Group Ltd Ordinary SharesCRISISQ -20$4.80-9.43%
- SLNBUYSilence Therapeutics plcRECOVERYQ 3$13.29+0.15%
Industry peers
FMP comparable companies · ranked by market cap
- SYREBUYSpyre Therapeutics, Inc.$9.2BBULLQ 11$106.49+0.15%
- IMNMBUYImmunome, Inc.$2.7BBULLQ 22$28.52-1.79%
- TRVIBUYTrevi Therapeutics, Inc.$2.5BBULLQ 22$17.96+0.67%
- PHVSBUYPharvaris N.V.$2.5BBULLQ 17$36.27+2.87%
- BCRXBUYBioCryst Pharmaceuticals, Inc.$2.4BRECOVERYQ 6$9.55+1.36%
- NTLABUYIntellia Therapeutics, Inc.$1.8BRECOVERYQ 3$12.84-2.18%
- MAZESELLMaze Therapeutics, Inc.$1.6BRECOVERYQ 40$29.43+0.58%
- WVESELLWave Life Sciences Ltd.$1.0BCRISISQ 9$5.29-3.21%
- ARDXSELLArdelyx, Inc.$961MCRISISQ 1$3.89-3.86%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 0
- GROWTH
- 3
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-43.2%
REV YoY-
ROE-72.1%
EPS YoY-
ROA-37.8%
GROSS88
OP-419
NET-404
[VALUATION]
P/E TTM-14.24
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B26.13
P/FCF-
EV/EBITDA-15.76
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E334.26
ALTMAN Z-
CURR RATIO6.32
ND/EBITDA-
BETA1.15
